Testicular Cancer

The role of imaging in the diagnosis, staging, and management of testicular cancer
OBJECTIVE: The objective of this article is to describe recent developments in imaging patients with testicular germ cell tumors (GCTs).
Down Rd., Sutton, Surrey SM2 5PT
Surrey, UK
UK
Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant ra
PURPOSE: Adjuvant radiation therapy (ART) for stage I seminoma can cause adverse late effects and alternative postorchiectomy management strategies have been developed.
375 Longwood Ave
Boston, MA 02115
USA
Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV s
The case of a young man with stage IV chemoresistant pure seminoma overexpressing KIT, who achieved complete remission (CR) after the administration of imatinib mesylate (400 mg once daily), along with a third-line chemotherapy regimen, consisting of paclitaxel (150 mg/m2), oxaliplatin (100 mg/m2) and gemcitabine (800 mg/m2) every 2 weeks with granulocyte colony-stimulating factor (G-CSF) support is reported.

Athens, Greece
Greece
Exploration of treatment options for the management of stage I testicular seminoma
Seminoma is the epitome of a highly treatable neoplastic malignancy.
44 Binney Street, Mayer 664
Boston, MA 02115
USA
Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated w
BACKGROUND: Cisplatin-based chemotherapy can cure more than 80% of metastatic germ cell testicular tumors (GCT).

Budapest, Hungary
Hungary